Stanislav Micuda

since 2012 Head of the Department

Charles University, Faculty of Medicine in Pilsen

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stanislav Micuda is the Head of the Department at the Faculty of Medicine in Hradec Kralove, Charles University, located in the Czech Republic. His research focuses on liver functionality, bile acid homeostasis, and the implications of various pharmacological agents on liver health. Recent articles authored by Professor Micuda explore topics such as the effects of dexamethasone on liver macrophages and the role of endoglin in liver dysfunction.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Lars Grøntved

University of Southern Denmark

DENMARK

View details

Samira Eissazadeh

Charles University

CZECH REPUBLIC

View details

Ivone Igreja Sá

Faculty of Pharmacy, Charles University

CZECH REPUBLIC

View details

Markus Felix Templin

Natural and Medical Sciences Institute

GERMANY

View details

Petr Pavek

Professor

Faculty of Pharmacy, Charles University

CZECH REPUBLIC

View details

Miguel Pericacho

Profesor Contratado Doctor

Universidad de Salamanca Facultad de Medicina

SPAIN

View details

Katarína Tripská

Assistant professor

Charles University

CZECH REPUBLIC

View details

Milos Hroch

Associate professor

Charles University in Prague, Faculty of Medicine in Hradec Kralove

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stanislav Micuda

Research Interests

Contact this professor

About

Articles (10)

Dexamethasone Acetate‐Loaded PLGA Nanospheres Targeting Liver Macrophages

Endoglin and soluble endoglin in liver sinusoidal endothelial dysfunction in vivo

An alternative approach to validation of liquid chromatography-mass spectrometry methods for the quantification of endogenous compounds

Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis.

Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis.

Development of a Rat Model of Intra-Amniotic Inflammation <i>via</i> Ultrasound-Guided Administration of a Triggering Agent in the Gestational Sac to Enable Analysis of Individual Amniotic Fluid Samples.

Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats.

Atorvastatin Modulates Bile Acid Homeostasis in Mice with Diet-Induced Nonalcoholic Steatohepatitis.

Off-target lipid metabolism disruption by the mouse constitutive androstane receptor ligand TCPOBOP in humanized mice.

(E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like Peptide-1 Secretion From Enteroendocrine Cells.

Collaborators (8)

Lars Grøntved

Samira Eissazadeh

Ivone Igreja Sá

Markus Felix Templin

Petr Pavek

Miguel Pericacho

Katarína Tripská

Milos Hroch

Make your next move.